TAD Technology platform
>TAD self-assembly therapy technology platform
TAD (Targeting & Delivery) is a modular engineering exosome therapy technology platform independently developed by the company. The platform relies on the company's own high purity Exosome large-scale GMP production platform, multi-dimensional integration of natural exosome delivery advantages and TAD molecular components precise controllable and modular characteristics, together to form a new generation of safe, targeted and efficient Exosome+ nucleic acid drug therapy system. Exosomes have high biocompatibility, no immunogenicity, no risk of genome integration, and high safety. The modular combination of specific targeting molecular elements endowing exosomes with precise targeting of tissues and cells; The high level of nucleic acid loading capacity of the loaded molecular element and the effective release of the loaded material in the target cell realize the efficient delivery of nucleic acid drugs. The system takes into account both safety and effectiveness. So far, the R&D team has used this technology to effectively deliver mRNA drugs, focusing on the treatment of major human diseases such as rare diseases and solid tumors.
